Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc.verified

COLL

Price:

$34.25

Market Cap:

$1.12B

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-05-07

Stock Exchange

NASDAQ

Ticker

COLL

The PE Ratio as of May 2024 (TTM) for Collegium Pharmaceutical, Inc. (COLL) is 13.65

According to Collegium Pharmaceutical, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 13.65. This represents a change of 28.29% compared to the average of 10.64 of the last 4 quarters.

Collegium Pharmaceutical, Inc. (COLL) Historical PE Ratio (quarterly & annually)

How has COLL PE Ratio performed in the past?

The mean historical PE Ratio of Collegium Pharmaceutical, Inc. over the last ten years is -10.41. The current 13.65 PE Ratio has changed -13209.23% with respect to the historical average. Over the past ten years (40 quarters), COLL's PE Ratio was at its highest in in the March 2020 quarter at 309.37. The PE Ratio was at its lowest in in the December 2019 quarter at -78.54.

Quarterly (TTM)
Annual

Average

-10.41

Median

-6.29

Minimum

-84.50

Maximum

25.76

Collegium Pharmaceutical, Inc. (COLL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Collegium Pharmaceutical, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 485.62%

Maximum Annual PE Ratio = 25.76

Minimum Annual Increase = -444.00%

Minimum Annual PE Ratio = -84.50

Quarterly (TTM)
Annual
YearPE RatioChange
202321.57-168.70%
2022-31.39-444.00%
20219.13-64.58%
202025.76-130.49%
2019-84.50485.62%
2018-14.4393.34%
2017-7.4686.04%
2016-4.01-70.64%
2015-13.66166.62%
2014-5.12-9.60%

Collegium Pharmaceutical, Inc. (COLL) Average PE Ratio

How has COLL PE Ratio performed in the past?

The current PE Ratio of Collegium Pharmaceutical, Inc. (COLL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.23

5-year avg

-11.89

10-year avg

-10.41

Collegium Pharmaceutical, Inc. (COLL) PE Ratio vs. Peers

How is COLL’s PE Ratio compared to its peers?

Collegium Pharmaceutical, Inc.’s PE Ratio is less than Phibro Animal Health Corporation (57.02), less than ANI Pharmaceuticals, Inc. (32.95), greater than Procaps Group S.A. (5.34), less than Silver Spike Investment Corp. (14.18), greater than Amphastar Pharmaceuticals, Inc. (13.48), greater than Eagle Pharmaceuticals, Inc. (2.57), greater than Alkermes plc (9.29), greater than Evolus, Inc. (-12.26), less than Prestige Consumer Healthcare Inc. (15.23), greater than Regencell Bioscience Holdings Limited (-11.10), less than Pacira BioSciences, Inc. (19.59), greater than Intra-Cellular Therapies, Inc. (-57.27), less than Dr. Reddy's Laboratories Limited (17.27),

Build a custom stock screener for Collegium Pharmaceutical, Inc. (COLL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Collegium Pharmaceutical, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Collegium Pharmaceutical, Inc. (COLL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Collegium Pharmaceutical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Collegium Pharmaceutical, Inc.'s PE Ratio?

How is the PE Ratio calculated for Collegium Pharmaceutical, Inc. (COLL)?

What is the highest PE Ratio for Collegium Pharmaceutical, Inc. (COLL)?

What is the 3-year average PE Ratio for Collegium Pharmaceutical, Inc. (COLL)?

What is the 5-year average PE Ratio for Collegium Pharmaceutical, Inc. (COLL)?

How does the current PE Ratio for Collegium Pharmaceutical, Inc. (COLL) compare to its historical average?